We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+46.64%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$642M
AUM Growth
+$78M
Cap. Flow
-$52.1M
Cap. Flow %
-8.12%
Top 10 Hldgs %
10.61%
Holding
350
New
118
Increased
46
Reduced
65
Closed
119

Top Buys

Rank Stock Value
1
RHP icon
Ryman Hospitality Properties
RHP
+$4.99M
2
AAON icon
Aaon
AAON
+$4.91M
3
DY icon
Dycom Industries
DY
+$4.34M
4
CVLT icon
Commault Systems
CVLT
+$4.32M
5
EXP icon
Eagle Materials
EXP
+$3.98M

Top Sells

Rank Stock Value
1
MTSI icon
MACOM Technology Solutions
MTSI
+$4.91M
2
CBAY
Cymabay Therapeutics
CBAY
+$4.89M
3
QLYS icon
Qualys
QLYS
+$4.82M
4
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$4.81M
5
RMBS icon
Rambus
RMBS
+$4.78M

Sector Composition

Rank Sector Weight
1 Industrials 26.28%
2 Healthcare 22.97%
3 Technology 20.59%
4 Consumer Discretionary 13.24%
5 Financials 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RDNT icon
101
RadNet
RDNT
$5.61B
$3.48M 0.54%
71,617
-22,839
-24% -$920K
GKOS icon
102
Glaukos
GKOS
$10.6B
$3.48M 0.54%
36,868
-9,460
-20% -$845K
PAY icon
103
Paymentus
PAY
$4.85B
$3.45M 0.54%
+151,790
New +$2.74M
NVT icon
104
nVent Electric
NVT
$26.6B
$3.44M 0.54%
45,677
+706
+2% +$45.3K
ANF icon
105
Abercrombie & Fitch
ANF
$5B
$3.41M 0.53%
27,234
-11,037
-29% -$1.26M
LBPH
106
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$3.38M 0.53%
+156,565
New +$3.41M
MEDP icon
107
Medpace
MEDP
$16.3B
$3.37M 0.53%
8,341
-4,087
-33% -$1.44M
LQDA icon
108
Liquidia Corp
LQDA
$8.01B
$3.37M 0.53%
+228,514
New +$3.18M
POWL icon
109
Powell Industries
POWL
$7.68B
$3.34M 0.52%
70,455
-44,424
-39% -$1.9M
NSSC icon
110
Napco Security Technologies
NSSC
$1.47B
$3.28M 0.51%
+81,753
New +$3.21M
GFF icon
111
Griffon
GFF
$4.87B
$3.23M 0.5%
44,103
-6,490
-13% -$424K
BHVN icon
112
Biohaven
BHVN
$2.23B
$3.19M 0.5%
58,364
-33,487
-36% -$1.66M
IOVA icon
113
Iovance Biotherapeutics
IOVA
$2.79B
$3.16M 0.49%
+213,336
New +$2.48M
IMNM icon
114
Immunome
IMNM
$2.81B
$3.16M 0.49%
+127,980
New +$2.6M
MOD icon
115
Modine Manufacturing
MOD
$10.3B
$3.12M 0.49%
32,759
-21,193
-39% -$1.64M
COLL icon
116
Collegium Pharmaceutical
COLL
$954M
$3.1M 0.48%
+79,949
New +$2.8M
FDMT icon
117
4D Molecular Therapeutics
FDMT
$565M
$3.07M 0.48%
+96,225
New +$2.45M
STNG icon
118
Scorpio Tankers
STNG
$3.81B
$3M 0.47%
+41,868
New +$2.84M
PCVX icon
119
Vaxcyte
PCVX
$8.6B
$2.99M 0.47%
+43,732
New +$3.03M
ALPN
120
DELISTED
Alpine Immune Sciences Inc
ALPN
$2.97M 0.46%
74,899
-87,786
-54% -$2.59M
CLSK icon
121
CleanSpark
CLSK
$3.17B
$2.95M 0.46%
139,283
-156,642
-53% -$2.18M
CLDX icon
122
Celldex Therapeutics
CLDX
$3.25B
$2.94M 0.46%
+70,115
New +$2.88M
CR icon
123
Crane Co
CR
$12.8B
$2.93M 0.46%
21,698
-10,256
-32% -$1.26M
CYTK icon
124
Cytokinetics
CYTK
$10.6B
$2.85M 0.44%
40,625
-6,580
-14% -$509K
SKWD icon
125
Skyward Specialty Insurance
SKWD
$2.58B
$2.84M 0.44%
75,784
-18,602
-20% -$629K
3 4
5
6 7

Similar funds

RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
WCM
Wallace Capital Management Dallas, Texas $871M AUM 13.69% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
F1I
Fund 1 Investments Rincon, Puerto Rico $872M AUM 50.95% 1-Year Est. Return

EAM Investors's Q1 2024 Portfolio in Review

As of Q1 2024, EAM Investors held 350 positions worth $642M, up 14% from $564M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

EAM Investors withdrew a net $52.1M in Q1 2024, closing 119 positions and reducing 65 holdings. Its most notable exit was MACOM Technology Solutions, an estimated $4.91M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

Against the trend, EAM Investors opened a new position in Ryman Hospitality Properties worth $5.03M.

  • EAM Investors's largest Q1 2024 buy was Ryman Hospitality Properties: 43,500 shares worth $5.03M.
  • EAM Investors added most to MoneyLion Inc. in Q1 2024, an estimated $2.13M increase.
  • EAM Investors's biggest Q1 2024 reduction was Viking Therapeutics, cutting an estimated $4.27M.
  • EAM Investors fully exited MACOM Technology Solutions in Q1 2024, selling an estimated $4.91M.
  • EAM Investors's ten largest holdings make up 11% of its $642M portfolio in Q1 2024.
  • EAM Investors opened 118 new positions and closed 119 in Q1 2024.
  • EAM Investors's portfolio value rose 14% quarter-over-quarter to $642M.

Based on EAM Investors's 13F filing for Q1 2024, filed 13 May 2024.